search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size

IDSA News Releases

11/09/2017

HPV Vaccine Also Prevents Uncommon Childhood Respiratory Disease, Study Suggests

HPV Vaccine Also Prevents Uncommon Childhood Respiratory Disease, Study Suggests The vaccine that protects against cancer-causing types of human papillomavirus (HPV) also prevents an uncommon but incurable childhood respiratory disease, according to a new study published in The Journal of Infectious Diseases.
11/02/2017

IDSA Launches Antimicrobial Stewardship Centers of Excellence Program

IDSA Launches Antimicrobial Stewardship Centers of Excellence Program Providence Saint John’s Health Center and Summa Health Among First to Receive the Distinction The Infectious Diseases Society of America (IDSA) is pleased to announce the first recipients of its Antimicrobial Stewardship Center of Santa Monica, California and Summa Health of Akron, Ohio.
11/01/2017

Fund Critical Health Programs without Compromising Public Health

Fund Critical Health Programs without Compromising Public Health 2017-11-01 November 1, 2017 Statement of IDSA President Paul Auwaerter, MD, FIDSA, HIVMA Chair Melanie Thompson, MD, PIDS President Paul Spearman, MD, FPIDS: The CHAMPION Act under consideration by the U.S. House of Representatives th
10/26/2017

Outpatient Antibiotics Raise Risk for Acquiring C. difficile Infection in the Community

Outpatient Antibiotics Raise Risk for Acquiring C. difficile Infection in the Community Study suggests recent emergency department visit may also be a risk factor Outpatient antibiotic use is a primary risk factor for acquiring Clostridium difficile infection in the community, reinforcing the need for appropriate prescribing in this setting, a new study published in Open Forum Infectious Diseases confirms.
10/19/2017

IDSA Infectious Diarrhea Guidelines Recommend When to Test, When to Treat, When to Notify Public Health Officials

New culture-independent molecular tests are much more sensitive than traditional diagnostic methods in detecting the cause of infectious diarrhea, a significant
10/19/2017

CDC updates guidance for infants born to mothers with possible Zika virus infection during pregnancy

CDC updates guidance for infants born to mothers with possible Zika virus infection during pregnancy 2017-10-19 Zika virus continues to be a public health threat to pregnant women and their infants. Despite the lower number of Zika cases in 2017 than at this time during 2016, Zika cases continue to be
10/12/2017

President Trump’s Executive Order on Health Insurance

Statement of HIVMA Chair Melanie Thompson, MD: The HIV Medicine Association is deeply concerned about the potential impact on persons living with HIV of the Executive Order signed today by the President.    
10/11/2017

Puerto Rico and U.S. Virgin Islands Need Urgent Aid Now to Avert Public Health Crises

The members of IDSA and HIVMA are deeply concerned that Puerto Rico and the U.S. Virgin Islands will face worsening public health crises in the wake of Hurricanes Maria and Irma.
10/05/2017

Leading Infectious Diseases Experts Honored at IDWeek 2017 for Outstanding Work in Advancing Patient Health

Among the 10 exceptional individuals being honored by the Infectious Diseases Society of America (IDSA) and the IDSA Foundation  at IDWeek 2017 in San Diego is Barbara E. Murray, MD, FIDSA, recipient of the Alexander Fleming Award for lifetime achievement.
10/05/2017

Children Learn About Illness-Causing Bugs Firsthand

SAN DIEGO – How do you get kids to understand the importance of washing their hands? Make it an experiment, suggests one study in which second graders observed that washing or using sanitizer gel reduced the bacteria on their hands by more than 90 percent.
10/04/2017

Paul Auwaerter, MD, MBA, FIDSA, Named IDSA President

The Infectious Diseases Society of America (IDSA) is pleased to announce Paul Auwaerter, MD, MBA, FIDSA, as the Society’s new president.
10/02/2017

HCV Guidance Website Address Kidney Transplantation, Pregnancy and HCV in Children

HCV Guidance Website Address Kidney Transplantation, Pregnancy and HCV in Children 2017-10-02 HCVguidelines.org - a website  developed by the American Association of the Study for Liver Diseases and the Infectious Diseases Society of America to provide up-to-date guidance on the treatment of hepatitis C
09/28/2017

Impact of Reaching U.S. Goals for HIV Treatment Would Be Massive and Cost-Effective

A new JID study finds that achieving U.S. goals for HIV treatment would avert nearly 200,000 deaths, prevent about 280,000 new infections, and would also be cost-effective.
09/22/2017

Message to Our Members Traveling to San Diego for IDWeek 2017

Message to Our Members Traveling to San Diego for IDWeek 2017 2017-09-22 As you may know, San Diego has had a rise in Hepatitis A cases, primarily among its homeless population. We are confident that travel to San Diego is safe.   We do urge visitors to follow standard good hygiene, washing y
09/21/2017

IDSA Statement on the Graham-Cassidy Bill, and its impact on the Prevention and Public Health Fund

IDSA Statement on the Graham-Cassidy Bill, and its impact on the Prevention and Public Health Fund 2017-09-21 The Graham-Cassidy bill under consideration in the Senate raises serious concerns about the future of essential public health activities supported by the Prevention and Public Health Fund, whi
09/14/2017

Chronic Pain Common in People Living with HIV

Because ongoing pain is a significant problem that affects 39 to 85 percent of people living with HIV, everyone with the infection should be assessed for chronic pain, recommend guidelines released by the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases. 
09/08/2017

IDSA Statement on the Senate Appropriations action on the State and Foreign Operations and Labor, Health and Human Services FY 2018 funding bills

The members of the Infectious Diseases Society of America (IDSA) applaud Senate appropriators’ support for programs and initiatives addressing central and urgent public health and research priorities in the spending bills for fiscal year 2018 that they approved Thursday.
09/05/2017

Annals article highlights impact of Trump budget cuts on work to counter antimicrobial resistance

As the Senate funding committee prepares to consider its health spending bill this week, an article in the Annals of Internal Medicine released today draws attention to the effects that  lawmakers decisions will have on efforts to counter the major and growing public health threat of antimicrobial resistance.
08/31/2017

Infectious Diseases Society of America Honors 102 Distinguished Physicians, Scientists

Infectious Diseases Society of America Honors 102 Distinguished Physicians, Scientists 2017-08-31 The Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society, recognizes the distinguished physicians and scientists from the United States and around
08/31/2017

Hurricane Harvey: Responding to Public Health and Infectious Disease Threats

The membership of the Infectious Diseases Society of America and the HIV Medicine Association stand with the individuals, families and communities affected by flooding in the aftermath of Hurricane Harvey, and urge care, preparation and precautions in confronting health impacts that may pose risks in the days and weeks ahead.
07/13/2017

IDSA Statement on the House of Representatives State and Foreign Operations and Labor, Health and Human Services FY 2018 funding bills

IDSA thanks Congressional appropriators for prioritizing many critical public health and research programs, emphasizes need for full funding
07/11/2017

IDSA Statement on the Repeal of the Prevention and Public Health Fund

The Better Care Reconciliation Act of 2017 under consideration in the Senate would repeal the Prevention and Public Health Fund in FY2018, a source of support for essential public health activities.
07/11/2017

IDSA Commends G20 AMR and Global Health Commitments, Calls for US Action

IDSA applauded the G20 declaration’s commitment to efforts confronting antimicrobial resistance and its recognition of the need to respond global health challenges, and called for U.S. leadership funding and policies that support and reflect a leadership role.
07/07/2017

IDSA joins call for continued full PEPFAR coverage

Following Secretary of State Tillerson's testimony to Senate Appropriations sub-committee members on plans to limit the focus of the President's Emergency Plan for AIDS Relief to 11 countries, IDSA joined  HIVMA and 39 other organizations in a letter to the Secretary and Congressional leaders, highlighting the value of PEPFAR efforts and urging continued support for its goals. The letter is here. 
07/07/2017

IDSA Statement on the Appointment of Dr. Brenda Fitzgerald as Director of CDC

The Infectious Diseases Society of America congratulates Dr. Brenda Fitzgerald on her appointment to lead the Centers for Disease Control and Prevention at this critical time.
06/27/2017

IDSA Leads Diverse Group Calling for Antimicrobial Resistance Funding

The Infectious Diseases Society of America has sent a letter signed by more than 60 organizations urging congressional appropriations leaders to reject President Trump's  proposed cuts to federal funding for efforts to confront antimicrobial resistance and to maintain the bipartisan commitment to this issue.  The letter details why a multifaceted domestic and global response is required to stem the threat antimicrobial resistance poses to patient safety and public health.
06/22/2017

Studies of Lassa Fever Patient Evacuated to U.S. Offer Clues About Body’s Immune Response, Viral Persistence

When an American nurse working in West Africa became ill with Lassa fever and was evacuated to the U.S. for treatment in 2016, it provided a rare opportunity.
06/22/2017

IDSA Calls for Robust NIH Funding to Counter Infectious Disease Threats at Home and Abroad

On June 22, National Institutes of Health Director Francis Collins will testify before the Senate Labor, Health and Human Services, Education, and Related Agencies Subcommittee on Appropriations on the administration’s NIH budget request for FY2018. 
06/22/2017

IDSA, AASLD Express Concerns About Cochrane Review of DAAs for Hep C

Leaders of IDSA and AASLD recently submitted a letter to the editors of the Cochrane Review expressing their concerns regarding a review of the benefits of direct acting antivirals in the treatment of hepatitis C. The Societies pointed to significant flaws in the analysis that led to misleading and harmful conclusions and urge the authors to retract the review or to revise their conclusions as they do a disservice to patients living with HCV infection.
06/13/2017

As hearings begin, IDSA calls for robust funding to counter infectious disease threats at home and abroad

This week Health and Human Services Secretary Tom Price and Secretary of State Rex Tillerson will testify before Congress on the administration’s budget request for 2018.
05/23/2017

IDSA Statement on the President’s Fiscal Year 2018 Budget Proposal

The Infectious Diseases Society of America urges Congress to reject the short-sighted and destructive approach to research and public health evidenced in the Trump administration’s proposed budget for 2018 Trump administration’s FY2018 budget.
05/22/2017

IDSA Welcomes World Health Assembly Update on Antimicrobial Resistance

The Infectious Diseases Society of America welcomes an update at the World Health Assembly demonstrating progress on the implementation of the global action plan on antimicrobial resistance adopted by the United Nations General Assembly in September 2016.
05/15/2017

Medical, science organizations call on Price to support National Institutes of Health

Inadvance of a May 17 U.S. House of Representatives hearing on funding for the National Institutes of Health, leaders of 27 major medical and scientific societies and research advocacy organizations asked Health and Human Services Director Tom Price to protect the National Institutes of Health and its Fogarty International Center in a letter outlining the Center’s critical contributions to health security and responses at home and abroad
05/05/2017

IDSA Statement on FY2017 Omnibus Funding Legislation

The Infectious Diseases Society of America (IDSA) is grateful to Congress for passing H.R. 244, the Consolidated Appropriations Act, with its support for valuable infectious disease programs that will help protect public health in the United States and around the world.
04/10/2017

IDSA Education and Research Foundation Names Simintha Esson as New Chief Development Officer

Arlington, VA—The Infectious Diseases Society of America (IDSA) has named Simintha Esson to be Chief Development Officer (CDO) of the IDSA Education and Research Foundation, which serves as the charitable arm of the Society. Ms. Esson joins the Foundation at a time when the spread of diseases such as Zika and the resurgence of diseases long since considered under control like malaria and cholera are drawing considerable national attention.  
03/31/2017

Tax Credit Bill Introduced

The undersigned organizations representing healthcare providers, hospitals, pharmacists, scientists and microbiologists, industry, public health experts, patients and advocates write to express our support for the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act of 2017, H.R. 1840.
03/28/2017

IDSA and HIVMA Statement on Trump Proposed FY2017 Cuts

The Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) are alarmed by the Trump administration’s proposed cuts to FY2017 funding for the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC) public health preparedness and response grants, global and domestic HIV and TB efforts at the CDC, and global health programs at the United States Agency for International Development (USAID) and the State Department.
03/16/2017

IDSA Statement on the Trump Budget Blueprint

The Infectious Diseases Society of America (IDSA) is deeply troubled that the budget blueprint released today by the Trump administration proposes a $5.8 billion cut to the National Institutes of Health (NIH) and cuts to the Health and Human Services (HHS) emergency preparedness programs.
03/09/2017

IDSA Statement on the Repeal of the Prevention and Public Health Fund

The Infectious Diseases Society of America (IDSA) is deeply concerned that the proposed American Health Care Act under consideration in Congress would repeal the Prevention and Public Health Fund.
02/27/2017

IDSA Statement on WHO Priority AR Pathogen List

The Infectious Diseases Society of America welcomes today’s announcement from the World Health Organization of its “priority pathogens” list to guide and promote antibiotic research and development. We call upon United States policy makers and international leaders to commit the resources necessary to realize the goals of this list.
02/16/2017

Complex Neurological Infections Require Team Care

A team approach is vital to the successful diagnosis and treatment of complex neurological infections related to placement of devices in the brain, or as a result of neurosurgery or head trauma. This is among the recommendations in the first comprehensive guidelines on healthcare-associated ventriculitis and meningitis, which are being released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases.
02/10/2017

IDSA Statement on the Confirmation of Tom Price as Secretary of Health and Human Services

The Infectious Diseases Society of America is committed to working with Secretary Price, confirmed today by the U.S. Senate as the new Secretary of the Department of Health and Human Services.
02/02/2017

IDSA Statement on Exec. Order on Travel to U.S.

Infectious diseases do not respect national borders, and success in fighting them requires a global response. Broad international collaboration is critical to our ability to identify, track and respond to emerging infectious diseases. 
01/11/2017

IDSA Statement on Vaccines

The Infectious Diseases Society of America (IDSA) stands behind the overwhelming scientific evidence that has repeatedly demonstrated the overall safety and benefit of routine childhood vaccinations. Children are far more likely to be harmed by vaccine preventable illness, such as measles, than by the vaccines that prevent such infections.
//

A JID studysuggests the high-dose flu vaccine was more effective at preventing deaths among seniors than the standard-dose vaccine during a more severe flu season.
//

At a Glance An experiment with Petri dishes and black lights helped second graders observe the value of hand hygiene, according to an IDWeek 2017 study. Students cultured their hands before and after they washed or used hand sanitizer and observed a 91 percent decrease in bacteria in the clean-hand vs. the dirty-hand cultures. A black light helped students see remaining simulated germs on their hands they missed with hand washing or sanitizing. Teachers observed an increase in students’ compliance with washing their hands. Also, illness-related student absences decreased by 71 percent in the 30 days after the experiment began.
//

At A Glance All people living with HIV should be screened for chronic pain, which affects 39 to 85 percent of people with the condition, recommend new HIVMA guidelines.  Those who have chronic pain should be treated using a multidisciplinary approach focused on non-drug options ranging from yoga to physical therapy, note the guidelines. Opioids should never be a first-line treatment.   Almost half of all chronic pain in people with HIV is neuropathic (nerve) pain, which researchers believe is due to inflammation caused by the infection to the central or peripheral nervous system. 
//

IDSA Launches Antimicrobial Stewardship Centers of Excellence Program

IDSA Launches Antimicrobial Stewardship Centers of Excellence Program Providence Saint John’s Health Center and Summa Health Among First to Receive the Distinction The Infectious Diseases Society of America (IDSA) is pleased to announce the first recipients of its Antimicrobial Ste

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site